Compare SKWD & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SKWD | PGNY |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | 680 |
| Industry | Property-Casualty Insurers | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2022 | 2019 |
| Metric | SKWD | PGNY |
|---|---|---|
| Price | $48.57 | $17.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $64.80 | $27.60 |
| AVG Volume (30 Days) | 538.2K | ★ 1.5M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.81 | 14.04 |
| EPS | ★ 4.07 | 0.65 |
| Revenue | ★ $1,416,541,000.00 | $1,288,661,000.00 |
| Revenue This Year | $31.66 | $10.74 |
| Revenue Next Year | $13.67 | $10.93 |
| P/E Ratio | ★ $11.87 | $27.02 |
| Revenue Growth | ★ 23.16 | 10.40 |
| 52 Week Low | $42.45 | $16.76 |
| 52 Week High | $65.05 | $28.75 |
| Indicator | SKWD | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 29.38 |
| Support Level | $43.94 | N/A |
| Resistance Level | $50.44 | $23.73 |
| Average True Range (ATR) | 1.83 | 1.00 |
| MACD | 0.42 | -0.26 |
| Stochastic Oscillator | 90.42 | 18.92 |
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.